These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2422798)

  • 1. Positive direct antiglobulin tests associated with intravenous gamma globulin use in bone marrow transplant recipients.
    Whitsett CF; Pierce JA; Daffin LE
    Transplantation; 1986 May; 41(5):663-4. PubMed ID: 2422798
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
    Kapoor N; Copelan EA; Tutschka PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 4. Ganciclovir in the treatment of cytomegalovirus pneumonitis in bone marrow transplant recipients.
    Milliken S; Powles R; Ettinger N; Gallagher C; Jameson B; Tryhorn Y; Stern H; Selby P
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3110-1. PubMed ID: 2539692
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic use of immunoglobulin in bone marrow transplantation.
    Ho WG; Winston DJ; Champlin RE; Gale RP
    Int J Cell Cloning; 1986; 4 Suppl 1():174-80. PubMed ID: 3018101
    [No Abstract]   [Full Text] [Related]  

  • 6. Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation.
    Elfenbein G; Krischer J; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3099-100. PubMed ID: 2539688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interstitial pneumonia in bone marrow transplantation. Preventive and therapeutic aspects. Our experience and review of the literature].
    Zabala P; Campano F; Candela MJ; Regidor C; Cabrera R; Sanjuán I; Barbolla L; Fernández MN
    Sangre (Barc); 1989 Dec; 34(6):489-96. PubMed ID: 2483466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interstitial pneumonia in leukemia patients after allogeneic bone marrow transplantation].
    Yamauchi T; Miyamura K; Nomura S; Minami S; Yoshikawa H; Sakai S; Yoshikawa S; Kodera Y; Sao H; Tahara T
    Rinsho Ketsueki; 1986 Aug; 27(8):1361-8. PubMed ID: 3025473
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin.
    Condie RM; O'Reilly RJ
    Dev Biol Stand; 1982; 52():501-13. PubMed ID: 6299859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
    Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
    Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
    Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
    Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues concerning the use of intravenous immunoglobulins for the immunoprophylaxis of cytomegalovirus infections in allogeneic bone marrow transplant recipients.
    Emanuel D
    Monogr Allergy; 1988; 23():216-24. PubMed ID: 2838745
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation.
    Jacobsen N; Schäfer U; Ostendorf P; Kubaneck B; Wolf H
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):193-5. PubMed ID: 3010510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
    Schmidt GM; Kovacs A; Zaia JA; Horak DA; Blume KG; Nademanee AP; O'Donnell MR; Snyder DS; Forman SJ
    Transplantation; 1988 Dec; 46(6):905-7. PubMed ID: 2849818
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation.
    Choi JH; Kim DW; Cho SG; Yoo JH; Jeong DC; Han CW; Shin WS; Min WS; Kim HK; Kim CC; Kim DJ
    Bone Marrow Transplant; 1997 Jan; 19(2):187-90. PubMed ID: 9116619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study.
    Narvios AB; Lichtiger B
    Haematologica; 2001 Jul; 86(7):749-52. PubMed ID: 11454531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Category, quantity and clinical significance of autoantibodies on bone marrow hematopoietic cells in patients with immunorelated cytopenia].
    Fu R; Shao ZH; Liu H; He H; Jia HR; Sun J; Zhao MF; He GS; Shi J; Bai J; Chu YL; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):177-80. PubMed ID: 12864946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.